Aktis Oncology, Inc. (AKTS) research
Aktis Oncology, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $18.52
- As of
Kresmion compiles this page from AKTS's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Aktis Oncology, Inc. (AKTS): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-13.
As of . Source: SEC EDGAR filings for AKTS. Method and limitations.
Share the AKTS intelligence card
See the full AKTS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AKTS on one page. Preview it with sample data, then open it live with a free account.
Preview the AKTS dossierActive signals for AKTS
- highCONSENSUS_BUY
3 tracked funds increased AKTS this 2026Q2, institutional consensus
- mediumNEW_POSITION
CITADEL ADVISORS LLC new position in AKTS
- mediumNEW_POSITION
RENAISSANCE TECHNOLOGIES LLC new position in AKTS
- mediumNEW_POSITION
TWO SIGMA INVESTMENTS, LP new position in AKTS
- mediumNEW_POSITION
D. E. Shaw & Co., Inc. new position in AKTS
FREE, NO ACCOUNT
Every signal on AKTS, as it fires
You are seeing 5 of 8 signals recorded on AKTS since 2026-06-09.
The five above landed across 2 days. The other 3 were recorded on 2 other days. 5 of the 8 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in AKTS (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| SOROS FUND MANAGEMENT LLCCUSIP 01021M104 · 2026Q2 | $3.2M | 0.04% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 01021M104 · 2026Q2 | $3.1M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 01021M104 · 2026Q2 | $996K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 01021M104 · 2026Q2 | $823K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, AKTS
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Follow AKTS on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to AKTS for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.